Hydroxamic Acid-Modified Peptide Library Provides Insights into the Molecular Basis for the Substrate Selectivity of

Lewis J Archibald1, Edward A Brown2, Christopher J Millard2

  • 1School of Chemistry, Advanced Research Centre, University of Glasgow, Glasgow G11 6EW, U.K.

ACS Chemical Biology
|August 16, 2022
PubMed
Summary

Targeting class I histone deacetylases (HDACs) offers therapeutic potential for diseases like HIV and cancer. This study reveals that the specific amino acid sequence around lysine residues influences HDAC complex activity, guiding drug development.